Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatma Merve Tepetam

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
International Archives of Allergy and Immunology|January 25, 2024
One-Bag 8-Step Ferric Carboxymaltose Desensitization Protocol for Patients with a History of Hypersensitivity Reactions to Iron PreparationsŞeyma Özden, Fatma Merve Tepetam, Özge Atik
Tuberkuloz Ve Toraks|June 22, 2023
[Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions]Şeyma Özden, Fatma Merve Tepetam, Özge Atik
Tuberkuloz Ve Toraks|March 13, 2023
Successful nintedanib desensitization: Due to two casesFatma Merve Tepetam, Şeyma Özden, Dildar Duman
Tuberkuloz Ve Toraks|April 15, 2021
The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthmaHasan Özgen, Fatma Merve Tepetam, İsmet Bulut, et al.
Medicine|October 31, 2023
The phenotypic heterogeneity of obese and nonobese patients with severe asthma and comparison of omalizumab-mepolizumab treatment efficiency in these patientsŞeyma Özden, Fatma Merve Tepetam, Cihan Örçen, et al.
The Libyan Journal of Medicine|October 28, 2024
Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticariaÖzge Atik, Fatma Merve Tepetam, Şeyma Özden, et al.
Postepy Dermatologii I Alergologii|July 17, 2025
Clinical characteristics of asthma-chronic obstructive pulmonary disease overlap phenotypesÖzge Atik, Fatma Merve Tepetam, Şeyma Özden, et al.
Tuberkuloz Ve Toraks|March 27, 2026
Successful and practical pirfenidone desensitizationŞeyma Özden, Fatma Merve Tepetam, Dildar Duman, et al.
Tuberkuloz Ve Toraks|December 20, 2022
Modified successful desensitization protocol of infliximab in a patient with sarcoidosis unable to tolerate corticosteroids and refractory to alternative therapeuticsFatma Merve Tepetam, Ravza Bayraktar, Erdoğan Çetinkaya, et al.
The World Allergy Organization Journal|March 4, 2025
Desensitization to colecalciferol in 18 patients with immediate hypersensitivity reactionsÖzge Atik, Fatma Merve Tepetam, Şeyma Özden, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
International Archives of Allergy and Immunology|January 25, 2024
One-Bag 8-Step Ferric Carboxymaltose Desensitization Protocol for Patients with a History of Hypersensitivity Reactions to Iron PreparationsŞeyma Özden, Fatma Merve Tepetam, Özge Atik
Tuberkuloz Ve Toraks|June 22, 2023
[Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions]Şeyma Özden, Fatma Merve Tepetam, Özge Atik
Tuberkuloz Ve Toraks|March 13, 2023
Successful nintedanib desensitization: Due to two casesFatma Merve Tepetam, Şeyma Özden, Dildar Duman
Tuberkuloz Ve Toraks|April 15, 2021
The significance of eosinophil and eosinophil lymphocyte ratio (ELR) in predicting response to omalizumab treatment in patients with severe allergic asthmaHasan Özgen, Fatma Merve Tepetam, İsmet Bulut, et al.
Medicine|October 31, 2023
The phenotypic heterogeneity of obese and nonobese patients with severe asthma and comparison of omalizumab-mepolizumab treatment efficiency in these patientsŞeyma Özden, Fatma Merve Tepetam, Cihan Örçen, et al.
The Libyan Journal of Medicine|October 28, 2024
Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticariaÖzge Atik, Fatma Merve Tepetam, Şeyma Özden, et al.
Postepy Dermatologii I Alergologii|July 17, 2025
Clinical characteristics of asthma-chronic obstructive pulmonary disease overlap phenotypesÖzge Atik, Fatma Merve Tepetam, Şeyma Özden, et al.
Tuberkuloz Ve Toraks|March 27, 2026
Successful and practical pirfenidone desensitizationŞeyma Özden, Fatma Merve Tepetam, Dildar Duman, et al.
Tuberkuloz Ve Toraks|December 20, 2022
Modified successful desensitization protocol of infliximab in a patient with sarcoidosis unable to tolerate corticosteroids and refractory to alternative therapeuticsFatma Merve Tepetam, Ravza Bayraktar, Erdoğan Çetinkaya, et al.
The World Allergy Organization Journal|March 4, 2025
Desensitization to colecalciferol in 18 patients with immediate hypersensitivity reactionsÖzge Atik, Fatma Merve Tepetam, Şeyma Özden, et al.
Pageof 5